Literature DB >> 10365097

Clinicopathological implications of parathyroid hormone-related protein in human colorectal tumours.

M Nishihara1, M Ito, T Tomioka, A Ohtsuru, T Taguchi, T Kanematsu.   

Abstract

The purpose of the present study was to clarify the relationship of parathyroid hormone-related protein (PTHrP) to the oncogenesis and progression of colorectal adenocarcinoma. A total of 108 colorectal tumours, including 12 adenomas, six adenocarcinomas in adenomas, and 90 adenocarcinomas, were studied. Immunohistochemistry, in situ hybridization, and reverse transcription-polymerase chain reaction (RT-PCR) techniques were used to evaluate the expression of PTHrP. Positivity of immunostaining for PTHrP was defined as highly positive (++), slightly positive (+), and negative (-). None of the adenomas of background non-neoplastic mucosal epithelia showed immunostaining of PTHrP. In contrast, PTHrP was expressed in 85 (94.4 per cent) of 90 colorectal adenocarcinomas. Immunoreactivity of PTHrP was greater in poorly differentiated adenocarcinomas than in well-differentiated ones. Furthermore, advancing margins of primary tumours stained more intensely than other sites. Highly positive immunoreactivity of PTHrP, classified by histological invasiveness, was 22.6 per cent within the muscularis propria and 69.5 per cent beyond the muscularis propria. PTHrP expression was significantly correlated with differentiation, depth of invasion, lymphatic invasion, lymph node metastasis, hepatic metastases, and Dukes' classification. In carcinoma, PTHrP mRNA expression was evident in tumour cells by in situ hybridization. PTHrP transcripts were also detected in two resected human colorectal adenocarcinomas by RT-PCR. These findings suggest that PTHrP is related to carcinogenesis, differentiation, progression, and prognosis of colorectal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365097     DOI: 10.1002/(SICI)1096-9896(199901)187:2<217::AID-PATH210>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; B Mark Evers; Miriam Falzon
Journal:  Regul Pept       Date:  2007-01-10

2.  PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.

Authors:  Jiarong Li; Andrew C Karaplis; Dao C Huang; Peter M Siegel; Anne Camirand; Xian Fang Yang; William J Muller; Richard Kremer
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

3.  Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma.

Authors:  Makoto Tsuchimochi; Ayako Kameta; Mikiko Sue; Masataka Katagiri
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  PTHrP promotes colon cancer cell migration and invasion in an integrin α6β4-dependent manner through activation of Rac1.

Authors:  Ramanjaneya V Mula; Vandanajay Bhatia; Miriam Falzon
Journal:  Cancer Lett       Date:  2010-07-15       Impact factor: 8.679

5.  MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP.

Authors:  Rongjun Zhou; Zhen Luo; Guanqun Yin; Lanting Yu; Hao Zhong
Journal:  J Mol Histol       Date:  2022-01-09       Impact factor: 2.611

6.  Parathormone and 1,25(OH)2D3 but not 25(OH)D3 serum levels, in an inverse correlation, reveal an association with advanced stages of colorectal cancer.

Authors:  Anestis Charalampopoulos; Alexander Charalabopoulos; Anna Batistatou; Christos Golias; Antonia Anogeianaki; Dimitrios Peschos; Iosif Iliadis; Anastasios Macheras; Konstantinos Charalabopoulos
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

7.  Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival.

Authors:  V Bhatia; M K Saini; M Falzon
Journal:  Regul Pept       Date:  2009-07-17

8.  PTHrP increases xenograft growth and promotes integrin alpha6beta4 expression and Akt activation in colon cancer.

Authors:  Xiaoli Shen; Piotr G Rychahou; B Mark Evers; Miriam Falzon
Journal:  Cancer Lett       Date:  2007-10-26       Impact factor: 8.679

9.  PTHrP attenuates osteoblast cell death and apoptosis induced by a novel class of anti-cancer agents.

Authors:  Sahiti Chukkapalli; Edi Levi; Arun K Rishi; Nabanita S Datta
Journal:  Endocrine       Date:  2015-08-11       Impact factor: 3.633

10.  Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibody.

Authors:  Anne Camirand; Ibtihal Fadhil; Aimée-Lee Luco; Benoît Ochietti; Richard B Kremer
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.